Delivery Order SPE2DB24D2010-SPE2DB25FAAUD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,538.92 to AmerisourceBergen Drug Corp for XTAMPZA ER 36 mg capsules (100 count), with performance in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price delivery order was issued on August 5, 2025, with an ultimate completion date of August 6, 2025. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to compete openly for federal medical procurement requirements....
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,804.59 to AmerisourceBergen Drug Corp on August 12, 2025, for Xtampza ER Caps 27mg, a controlled-release opioid medication. This firm fixed-price delivery order represents a child contract action under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Xtampza ER Caps 9mg. The contract has a ceiling value of $5,374.40 and a period of performance through April 18, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,564,158,451 units of the pharmaceutical product XTAMPZA ER CAPS 27MG. The $3,833.76 contract has an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is associated with a larger $999,999,999.00 indefinite delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,061.58 firm fixed price delivery order is for the supply of 4,564,085,587 units of the prescription medication Xtampza ER 27 mg capsules. The contract has a period of performance through March 27, 2024 and does not have a set-aside designation. Amerisourcebergen...
- This is a $2,239.69 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Xtampza ER 9 mg capsules. The contract has a completion date of July 30, 2024 and was awarded on July 29, 2024. The contract is not set aside for any specific business designation. As a key supplier to federal healthcare programs, AmerisourceBergen leverages its extensive pharmaceutical supply chain to provide a...
- This is a $6,059.05 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of XTAMPZA ER CAPS 18MG, a prescription medication. The order has a completion date of July 18, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of XTAMPZA ER CAPS 36MG. The award has a ceiling value of $5,229.60 and an ultimate completion date of August 14, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a Delivery Order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $8,417.36 firm fixed-price contract is for the supply of Xtampza ER Capsules 36mg, a specialty medication used for pain management. The contract has an ultimate completion date of October 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a federal delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for XTAMPZA ER CAPS 36MG, a pharmaceutical product, with a ceiling value of $8,225.07. The contract is a firm fixed price, non-set-aside delivery order with a performance period ending on June 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FAAUDDelivery Order
The Defense Logistics Agency awarded a $1,218.07 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Xtampza ER 27 mg capsules (100-count package). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 13, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement needs, supplying medications across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/12/25 |